Our new review is out! We detail mechanisms by which the viral, bacterial, parasite, and other pathogens that infect humans over a lifetime accelerate features of aging: sciencedirect.com/science/articl…
2/ Specifically, viruses such as the herpesviruses, as well as intracellular bacteria & parasites—express proteins and metabolites capable of interfering with host immune signaling, #mitochondrial function, gene expression, and the #epigenetic environment.
3/ Pathogen activity also contributes directly to age-related disease development: for example, #Alzheimer’s amyloid-β plaque can act as an antimicrobial peptide that forms in response to infection. pubmed.ncbi.nlm.nih.gov/30001512/
4/ Indeed, because many pathogens dysregulate mTOR, AMPK, or related immunometabolic signaling, #healthspan interventions such as low-dose rapamycin, metformin, and NAD+ that target such pathways may exert part of their effect by controlling persistent infection.
5/ The lack of #diagnostics capable of detecting pathogen activity across a lifetime remains a major bottleneck. Emerging tools—such as ultrasensitive protein assays and antigen immune biosensor platforms—can enable integration of pathogen detection into biological age tracking.
6/ We are creating a @polybioRF program specifically focused on developing such diagnostics, which will innovate the longevity space. Message me if you want to learn more.
@polybioRF 7/ Overall we must incorporate infection into aging to models to accurately characterize drivers of #senescence and to optimize therapeutic strategies that target both host and microbial contributors to aging
@polybioRF 8/ Simply put: no one will succeed in extending healthspan/lifespan if they have a virus or parasite in their brain seeding Alzheimer’s plaque or distorting the epigenetic environment
@polybioRF 9/ And some of the therapeutic strategies capable of mitigating infectious contributions to aging are such low hanging fruit to implement
@polybioRF 10/ For example, this study found that people who routinely took over the counter anti-herpesvirus drugs were 10X less likely to develop Alzheimer’s disease later in life: pubmed.ncbi.nlm.nih.gov/29488144/
@polybioRF 11/ I'll be giving a @TEDx talk on infectious contributions to aging, and solutions to combat such age distortion this October in Boston. For now, check out this podcast where I go into more detail on the topic:
2/ Consider for example this study. The team identified dozens of viral proteins that distort human pathway signaling controlling #aging-associated processes such as senescence and apoptosis: pubmed.ncbi.nlm.nih.gov/36649176/
3/ Or this study - which found that human herpesvirus 6 can directly integrate into host telomeres. Telomeres carrying an integrated copy of the virus were shorter and more unstable: academic.oup.com/nar/article/42…
If you are a patient that meets #ME/CFS and #PEM criteria, info on the specific #infections or exposures that led to onset or exacerbation of your symptoms is of major importance. That info will help you pursue personalized treatment.
2/ That is because many of the infections you've sustained may still be #persisting in your body - in your tissue or nerves. These persistent infections can cause PEM symptoms by driving #mitochondrial dysfunction, blood vessel/perfusion issues, or #vagus nerve dysfunction
3/ If your symptoms started - or were exacerbated - by a #herpesvirus infection, such viruses persist in your system for life. Thus, treatment with herpesvirus #antivirals (e.g. the Pridgen Protocol which uses valacyclovir and Celebrex) has helped certain ME/CFS patients improve
Jawdropping data here showing dozens of #viruses - many rarely even discussed or tested for on a regular basis - in sewage collected from wastewater in multiple USA cities. The viruses are identified via unbiased sequencing that can identify any viral genome in the samples.
2/ Because the viruses are being identified in wastewater it's possible that some viruses are harbored by animals - for example cattle or birds - whose feces end up in the wastewater
3/ However, it's likely that most of the viruses being shed into wastewater come from infected humans. Viruses like the enteroviruses A, B, C, D68, Rhinoviruses A, B, C, Rotaviruses, Noroviruses, Rotaviruses, Mastadenoviruses, Adenoviruses, Rhinoviruses, Influenza viruses, etc.
Glad to have contributed to this new preprint. We found that some PVS participants had higher levels of circulating spike protein compared to controls.
This parallels #LongCovid where persistence of the SARS-CoV-2 #virus in patient tissue may also cause spike to periodically leak into blood
2/ For example, this study found #SARS-CoV-2 proteins including spike up to 1 year post-COVID in up to 25% of people tested. But identified spike was not a result of the COVID vaccine, since nearly all study participants had not received the vaccine: thelancet.com/journals/lanin…
3/ The same team also found SARS-CoV-2 spike protein encoding double-stranded RNA in LongCovid #gut tissue almost 2 years post-#infection. Such RNA is produced during active viral replication and thus wld not be vaccine derived: science.org/doi/10.1126/sc…
Today I write for the @latimes: Long COVID is solvable, but we need more clinical trials.
These include trials of drugs to clear #SARS-CoV-2 reservoirs: small pockets of the virus - or parts of the virus - that can persist long-term in people’s bodies.
2/ We are living in an epidemic of chronic #disease, with a growing number of pesticides, chemicals and food additives implicated in the declining health of Americans.
3/ Since 2019, another factor has been at play as well: The #SARS-CoV-2 virus has driven a huge increase in chronic #health consequences, broadly referred to as long COVID.
Our new Viewpoint is out! We draw from treatment strategies in HIV, Hep C & other infections, to detail key considerations for #LongCovid clinical trials targeting persistent #SARS-CoV-2. These include combination trials of drugs that target both the virus and the immune system: authors.elsevier.com/a/1kayZ5E-UogX…
2/ To maximize these trials, we must develop validated #biomarkers to detect persistent virus or protein in accessible fluids like blood & saliva. Such biomarkers will allow targeted recruitment of participants w/ viral persistence into trials - helping trials to meet endpoints
3/ This persistence biomarker development - and the #LongCovid trials of immunotherapies, monoclonals, antivirals and other drugs delineated in our Viewpoint - are huge opportunities for the #biotech space. Agile, action-oriented agencies like @ARPA_H should also rapidly engage